Skip to main content
. 2020 Oct 14;39(1):38–47. doi: 10.1200/JCO.20.02072

FIG 3.

FIG 3.

Cumulative incidences of (A) locoregional failures and (B) distant failures by treatment group, and (C) cumulative incidence of local failures in T3-T4 tumors, with and without dose escalation. In C, the hazard ratio (HR) refers to the comparison of the two radiation dose groups, stratified for cisplatin/cetuximab. RT, radiotherapy.